Last reviewed · How we verify

NCT05869045

POCUS and Respiratory Failure Prognosis Based on Diaphragmatic Dysfunction

Status unknown Last updated 22 May 2023
What this trial tests

trial testing Diaphragm shortening fraction measurement by point-of-care ultrasound. in Respiratory Failure in 432 participants. Status unknown.

Timeline
1 September 2023
Primary endpoint
1 March 2024
1 May 2024

Quick facts

Lead sponsorAzienda Ospedaliero-Universitaria di Modena
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment432
Start date1 September 2023
Primary completion1 March 2024
Estimated completion1 May 2024

Drugs / interventions tested

Conditions studied

Sponsor

Azienda Ospedaliero-Universitaria di Modena — full company profile →

Who can join

18 and older, any sex, with Respiratory Failure or Diaphragm Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the use of POCUS to assess diaphragmatic function and its association with clinical outcomes in patients with respiratory failure who are admitted to the emergency department.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Respiratory Failure

Currently open trials in the same condition.

Other Azienda Ospedaliero-Universitaria di Modena trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05869045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing